Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

42,030 stories, page 491 of 701

Advanced search

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Multi-omics integration for drug target discovery: What the data actually shows

Drug Discovery NewsOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

New cholesterol pill Lipfendra gets FDA approval: 2 experts weigh in

AOL.comOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

How FDA Review of VOXZOGO Full-Approval Data at BioMarin (BMRN) Has Changed Its Investment Story

simplywall.stOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Bombay HC Directs Fresh FDA Inspection Of Park Inn By Radisson Navi Mumbai, Sets Aside FSSAI Licence

Free Press JournalOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

FAMU Appoints Vanessa B. Sheppard as Dean of the College of Pharmacy and Pharmaceutical Sciences/ Institute of Public Health

Florida A&M University - FAMUOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

New cholesterol drug receives FDA approval

McKnight's Long-Term Care NewsOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

This Week at FDA: FDA staff raise concerns about peptide conflicts, top Democrat wants DOGE investigation, and more

RAPSOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Recall roundup: Dozens of popular everyday items have been recalled nationwide

WXIIOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

FDA Inspects MANIT Hostels After Students Fall Ill, Finds Alleged Hygiene Lapses

Free Press JournalOriginal source

🇺🇸Jul 18Researchatlasventure.comTier 2 · Direct publisher

The Plus-1 in “The Room Where It Happens”: A Survival Guide for Board Observers

Atlas VentureOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Industry wants more clarity on NGS for assessing gene therapy safety

RAPSOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech Rises as Investors Lean on Commercial Momentum and Pipeline Catalysts

Quiver QuantitativeOriginal source

🌍Jul 18Researchindicalab.comTier 2 · Direct publisher

New! ADC Target Scoring Module

Indica LabsOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

This Biotech Position Gave Us Gains In A Choppy Market

Investor's Business DailyOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Erasca: A Credible Rival To Revolution's Daroxonrasib, At A Cheaper Price Point (ERAS)

Seeking AlphaOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

John Maraganore Says Lilly’s Trillion-Dollar Bet Is a Race Against Its Own Obesity Franchise

finance.biggo.comOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors

MarketWatchOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

NKGen Biotech (NKGN) alters collateral on $5M credit facility

Stock TitanOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

PharmaCyte Biotech (PMCB) cancels erroneous stock option grant

Stock TitanOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

PharmaCyte Biotech (PMCB) amends Form 4 to cancel option grant

Stock TitanOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

PharmaCyte Biotech (PMCB) director corrects erroneous, cancelled option grant

Stock TitanOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

"Give time to comply": Shiv Sena's Sanjay Nirupam on FDA's milk packaging norms

indiagazette.comOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Health Headlines: Challenges, Outbreaks, and Innovations

DevdiscourseOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Thousands of Bottles of Prescription Antihistamine Recalled, FDA Notice Says

NTD NewsOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Experts: Ending adequate provision would shut down prescription drug ads

RAPSOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Novo Nordisk to launch lower-cost Ozempic copy in South Africa

ReutersOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Challenges, & Solutions to the Domestic Pharma Production Shift

Powder & Bulk SolidsOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Florida Biotech Firm Takes FDA to Court Over Biden Era Export Delays

Floridian PressOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Accenture (ACN) Secures Defense Contract for Pharmaceutical Solu

GuruFocusOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol

markets.businessinsider.comOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Former Biotech Executive Erica Bazerkanian Announces 2026 Strategic Expansion of DTC Apparel Brand Bold&Zeal

markets.businessinsider.comOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Expert Insights: Psychedelics, Cannabis, Drug Policy Shift

Mirage NewsOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026

The Manila TimesOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Zentalis Pharmaceuticals to Present at the European Society for Medical Oncology (ESMO) Congress 2026

GlobeNewswireOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Zentalis' Azenosertib Accepted for Rapid ESMO Survival Presentation

Stock TitanOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Sellas Life (SLS) Climbs 12% Ahead of ‘Potentially Company-Defining’ Clinical Trial Result

Yahoo Finance UKOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

DNTH Stock Pops As Phase 3 EMERGE Trial Kicks Off

StocksToTradeOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Mass. biotech: FDA to review experimental cancer drug after two rejections, 200+ layoffs

MassLiveOriginal source

🌍Jul 18discoverynews.google.comTier 2 · Trade media

GSK Drug From $2B Deal Sputters in Phase 3 Test in Chronic Cough

MedCity NewsOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Some telehealth GLP-1 prescriptions have little clinician oversight, little regulation

Healthcare BrewOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Ultragenyx Pharmaceutical Currently Down Eight Consecutive Days, on Pace for Longest Losing Streak Since December 2024 -- Data Talk

MoomooOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

2025 BIG Executive Summit: Supported Funding Models for Biotech

BioProcess InternationalOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Incyte: Profitable Biotech That Could Be Close To Exploding (NASDAQ:INCY)

Seeking AlphaOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Wegovy Pill Just Changed the GLP-1 Market. Here's Why Eli Lilly Stock Could Still Win

The Globe and MailOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

FDA Approves First Oral PCSK9 Inhibitor to Lower LDL Cholesterol in Adults with High Cholesterol

GlobeNewswireOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Ask an Expert: Psychedelics, cannabis, GLP-1s and drug policy changes

The Pennsylvania State UniversityOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

‘We Are Not Defending What Biden Did’: Blanche Answers Hawley On Abortion Pills

tippinsightsOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Pilot program to boost biotech manufacturing careers

Insight NewsOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

FDA raids two PMC hospitals over unsafe drug dispensing; suspends 10 licences of eateries, bakeries and d

The Times of IndiaOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

North Carolina receives $29.6 million settlement in pharmaceutical price-fixing conspiracy

YahooOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Should stem cell therapies be regulated as drugs? This biotech company is taking the FDA to court.

Yahoo FinanceOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

This Biotech Company Has Spent Nearly 3 Years in FDA Limbo

Reason MagazineOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Gates Medical Research Institute & Serum Institute of India to manufacture new TB vaccine candidate

BioSpectrum IndiaOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

UK Biotech Completes Cancer-Focused Co. Buy In £17M Deal

Law360Original source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

$1B Swiss biotech establishes US headquarters in the Queen City

Yahoo FinanceOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Jyong Biotech Ltd. (NASDAQ:MENS) Short Interest Down 36.2% in June

MarketBeatOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Langham Logistics leans into pharmaceutical cold storage

Indianapolis Business JournalOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Serum Institute to manufacture potential first TB vaccine in over 100 years under Gates MRI deal

Northeast HeraldOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Blue Owl-Backed Latigo Files for IPO, Adding to Biotech Pipeline

Bloomberg.comOriginal source

🌍Jul 18discoverynews.google.comTier 3 · Aggregated media

Oramed stock trades quietly as diabetes pill strategy pivots after FDA setback

ad-hoc-news.deOriginal source